Each of these biotech stocks has more than tripled year to date and could still have plenty of room to run.
News & Analysis: ALTIMMUNE INC
These biotechs are developing coronavirus vaccines with a twist.
Just follow these three simple steps.
It's not a surprise that all five of these stocks are engaged in the fight against the novel coronavirus.
Some investors appear to be taking profits off the table with the high-flying biotech stock.
It’s tough to top quadruple-digit growth.
Here's what drove shares of these healthcare stocks through the roof last month.
Good news for Moderna was bad news for several of its rivals.
Investors are cheering the biotech's good news from its preclinical testing of an intranasal COVID-19 vaccine candidate.
Both of these small-cap vaccine stocks are up big in 2020.